Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis

Claudia L. Ordoñez, Noreen R. Henig, Nicole Mayer-Hamblett, Frank J. Accurso, Jane L. Burns, James F. Chmiel, Cori L. Daines, Ronald L. Gibson, Sharon McNamara, George Z. Retsch-Bogart, Pamela L. Zeitlin, Moira L. Aitken

Research output: Contribution to journalArticle

Abstract

Induced sputum has been used to study airway Inflammation. We sought to determine whether markers of Infection and inflammation in induced sputum were a useful and safe outcome measure in cystic fibrosis. We hypothesized that bacterial density and inflammatory content of induced sputum would decrease after antibiotic therapy. Induced sputum was assayed for bacterial density, cell count, and differential and inflammatory markers before and after treatment with intravenous antibiotics. Fifty-five of the 72 subjects enrolled (mean age ± SD 18.2 ± 7.9 years) completed the study. FEV 1 increased by an average 0.3 ± 0.3 L (10.4 ± 8.7% predicted FEV1), p <0.0001; density of Pseudomonas aeruginosa and Staphylococcus aureus decreased by 2.4 ± 3.1 log10 cfu/g (p <0.0005) and 4.0 ± 2.3 log10 cfu/ml (p <0.0001), respectively; neutrophil count decreased by 0.4 ± 0.6 log10 cells/ml (p <0.0001), interleukin-8 concentration by 0.5 ± 1.3 log10 pg/ml (p <0.05), and neutrophil elastase by 0.4 ± 0.7 log10 μg/ml (p <0.005). Seven of 127 (6%) sputum induction procedures showed a decrease in FEV1 of 20% or more. We conclude that markers in induced sputum may be useful, noninvasive outcome measures to assess response to therapies in cystic fibrosis studies.

Original languageEnglish (US)
Pages (from-to)1471-1475
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume168
Issue number12
DOIs
StatePublished - Dec 15 2003
Externally publishedYes

Fingerprint

Sputum
Cystic Fibrosis
Anti-Bacterial Agents
Outcome Assessment (Health Care)
Inflammation
Leukocyte Elastase
Interleukin-8
Pseudomonas aeruginosa
Staphylococcus aureus
Neutrophils
Cell Count
Therapeutics
Infection

Keywords

  • Bacterial density
  • Cystic fibrosis
  • Induced sputum
  • Inflammatory markers

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Ordoñez, C. L., Henig, N. R., Mayer-Hamblett, N., Accurso, F. J., Burns, J. L., Chmiel, J. F., ... Aitken, M. L. (2003). Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine, 168(12), 1471-1475. https://doi.org/10.1164/rccm.200306-731OC

Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis. / Ordoñez, Claudia L.; Henig, Noreen R.; Mayer-Hamblett, Nicole; Accurso, Frank J.; Burns, Jane L.; Chmiel, James F.; Daines, Cori L.; Gibson, Ronald L.; McNamara, Sharon; Retsch-Bogart, George Z.; Zeitlin, Pamela L.; Aitken, Moira L.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 168, No. 12, 15.12.2003, p. 1471-1475.

Research output: Contribution to journalArticle

Ordoñez, CL, Henig, NR, Mayer-Hamblett, N, Accurso, FJ, Burns, JL, Chmiel, JF, Daines, CL, Gibson, RL, McNamara, S, Retsch-Bogart, GZ, Zeitlin, PL & Aitken, ML 2003, 'Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis', American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 12, pp. 1471-1475. https://doi.org/10.1164/rccm.200306-731OC
Ordoñez, Claudia L. ; Henig, Noreen R. ; Mayer-Hamblett, Nicole ; Accurso, Frank J. ; Burns, Jane L. ; Chmiel, James F. ; Daines, Cori L. ; Gibson, Ronald L. ; McNamara, Sharon ; Retsch-Bogart, George Z. ; Zeitlin, Pamela L. ; Aitken, Moira L. / Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis. In: American Journal of Respiratory and Critical Care Medicine. 2003 ; Vol. 168, No. 12. pp. 1471-1475.
@article{f5b8560a5a3542aca3dc50f4187f4c73,
title = "Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis",
abstract = "Induced sputum has been used to study airway Inflammation. We sought to determine whether markers of Infection and inflammation in induced sputum were a useful and safe outcome measure in cystic fibrosis. We hypothesized that bacterial density and inflammatory content of induced sputum would decrease after antibiotic therapy. Induced sputum was assayed for bacterial density, cell count, and differential and inflammatory markers before and after treatment with intravenous antibiotics. Fifty-five of the 72 subjects enrolled (mean age ± SD 18.2 ± 7.9 years) completed the study. FEV 1 increased by an average 0.3 ± 0.3 L (10.4 ± 8.7{\%} predicted FEV1), p <0.0001; density of Pseudomonas aeruginosa and Staphylococcus aureus decreased by 2.4 ± 3.1 log10 cfu/g (p <0.0005) and 4.0 ± 2.3 log10 cfu/ml (p <0.0001), respectively; neutrophil count decreased by 0.4 ± 0.6 log10 cells/ml (p <0.0001), interleukin-8 concentration by 0.5 ± 1.3 log10 pg/ml (p <0.05), and neutrophil elastase by 0.4 ± 0.7 log10 μg/ml (p <0.005). Seven of 127 (6{\%}) sputum induction procedures showed a decrease in FEV1 of 20{\%} or more. We conclude that markers in induced sputum may be useful, noninvasive outcome measures to assess response to therapies in cystic fibrosis studies.",
keywords = "Bacterial density, Cystic fibrosis, Induced sputum, Inflammatory markers",
author = "Ordo{\~n}ez, {Claudia L.} and Henig, {Noreen R.} and Nicole Mayer-Hamblett and Accurso, {Frank J.} and Burns, {Jane L.} and Chmiel, {James F.} and Daines, {Cori L.} and Gibson, {Ronald L.} and Sharon McNamara and Retsch-Bogart, {George Z.} and Zeitlin, {Pamela L.} and Aitken, {Moira L.}",
year = "2003",
month = "12",
day = "15",
doi = "10.1164/rccm.200306-731OC",
language = "English (US)",
volume = "168",
pages = "1471--1475",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "12",

}

TY - JOUR

T1 - Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis

AU - Ordoñez, Claudia L.

AU - Henig, Noreen R.

AU - Mayer-Hamblett, Nicole

AU - Accurso, Frank J.

AU - Burns, Jane L.

AU - Chmiel, James F.

AU - Daines, Cori L.

AU - Gibson, Ronald L.

AU - McNamara, Sharon

AU - Retsch-Bogart, George Z.

AU - Zeitlin, Pamela L.

AU - Aitken, Moira L.

PY - 2003/12/15

Y1 - 2003/12/15

N2 - Induced sputum has been used to study airway Inflammation. We sought to determine whether markers of Infection and inflammation in induced sputum were a useful and safe outcome measure in cystic fibrosis. We hypothesized that bacterial density and inflammatory content of induced sputum would decrease after antibiotic therapy. Induced sputum was assayed for bacterial density, cell count, and differential and inflammatory markers before and after treatment with intravenous antibiotics. Fifty-five of the 72 subjects enrolled (mean age ± SD 18.2 ± 7.9 years) completed the study. FEV 1 increased by an average 0.3 ± 0.3 L (10.4 ± 8.7% predicted FEV1), p <0.0001; density of Pseudomonas aeruginosa and Staphylococcus aureus decreased by 2.4 ± 3.1 log10 cfu/g (p <0.0005) and 4.0 ± 2.3 log10 cfu/ml (p <0.0001), respectively; neutrophil count decreased by 0.4 ± 0.6 log10 cells/ml (p <0.0001), interleukin-8 concentration by 0.5 ± 1.3 log10 pg/ml (p <0.05), and neutrophil elastase by 0.4 ± 0.7 log10 μg/ml (p <0.005). Seven of 127 (6%) sputum induction procedures showed a decrease in FEV1 of 20% or more. We conclude that markers in induced sputum may be useful, noninvasive outcome measures to assess response to therapies in cystic fibrosis studies.

AB - Induced sputum has been used to study airway Inflammation. We sought to determine whether markers of Infection and inflammation in induced sputum were a useful and safe outcome measure in cystic fibrosis. We hypothesized that bacterial density and inflammatory content of induced sputum would decrease after antibiotic therapy. Induced sputum was assayed for bacterial density, cell count, and differential and inflammatory markers before and after treatment with intravenous antibiotics. Fifty-five of the 72 subjects enrolled (mean age ± SD 18.2 ± 7.9 years) completed the study. FEV 1 increased by an average 0.3 ± 0.3 L (10.4 ± 8.7% predicted FEV1), p <0.0001; density of Pseudomonas aeruginosa and Staphylococcus aureus decreased by 2.4 ± 3.1 log10 cfu/g (p <0.0005) and 4.0 ± 2.3 log10 cfu/ml (p <0.0001), respectively; neutrophil count decreased by 0.4 ± 0.6 log10 cells/ml (p <0.0001), interleukin-8 concentration by 0.5 ± 1.3 log10 pg/ml (p <0.05), and neutrophil elastase by 0.4 ± 0.7 log10 μg/ml (p <0.005). Seven of 127 (6%) sputum induction procedures showed a decrease in FEV1 of 20% or more. We conclude that markers in induced sputum may be useful, noninvasive outcome measures to assess response to therapies in cystic fibrosis studies.

KW - Bacterial density

KW - Cystic fibrosis

KW - Induced sputum

KW - Inflammatory markers

UR - http://www.scopus.com/inward/record.url?scp=9144237586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144237586&partnerID=8YFLogxK

U2 - 10.1164/rccm.200306-731OC

DO - 10.1164/rccm.200306-731OC

M3 - Article

C2 - 12969869

AN - SCOPUS:9144237586

VL - 168

SP - 1471

EP - 1475

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 12

ER -